Lapatinib

Saved in:
Bibliographic Details
Published inDrugs (New York, N.Y.) Vol. 67; no. 14; pp. 2101 - 2110
Main Authors DHILLON, Sohita, WAGSTAFF, Antona J
Format Journal Article
LanguageEnglish
Published Auckland Adis International 2007
Subjects
Antineoplastic agents
Antineoplastic Agents - adverse effects
Antineoplastic Agents - pharmacokinetics
Antineoplastic Agents - therapeutic use
Biological and medical sciences
Breast Neoplasms - drug therapy
Chemotherapy
Female
Gynecology. Andrology. Obstetrics
Humans
Mammary gland diseases
Medical sciences
Pharmacology. Drug treatments
Protein Kinase Inhibitors - adverse effects
Protein Kinase Inhibitors - pharmacokinetics
Protein Kinase Inhibitors - therapeutic use
Quinazolines - adverse effects
Quinazolines - pharmacokinetics
Quinazolines - therapeutic use
Receptor, Epidermal Growth Factor - antagonists & inhibitors
Receptor, ErbB-2 - antagonists & inhibitors
Tumors
Antineoplastic agent
Human
Monograph
Toxicity
erbB2 Gene
Breast cancer
Malignant tumor
Review
Metastasis
Mammary gland diseases
Technical card
Advanced stage
Lapatinib
Pharmacokinetics
Online AccessGet full text

Cover

More Information
ISSN:0012-6667
1179-1950
DOI:10.2165/00003495-200767140-00008